The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Croatia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age over 18
Untreated or ineffectively treated arterial hypertension

Exclusion criteria

Cholestatic disorders and severe hepatic failure
Allergy to telmisartan
Pregnancy and lactation period

Treatment and study plan

Pritor (Telmisartan , BAY68-9291)

Drug

Primary care hypertensive patients starting the therapy with Telmisartan

Primary outcomes

Efficacy and safety of the treatment with telmisartan reported by the physician

Time frame: At the both of planned control visits. (Approx. interval between visits 3 months)

Secondary outcomes

Changes in metabolic parameters in telmisartan treated patients

Time frame: At the both of planned control visits. (Approx. interval between visits 3 months)

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients

Acronym: METABOLIC

Important dates

Study start: 2006
Primary completion: 2009
Study completion: 2009
First posted: May 8, 2007
Registry last updated: Jan 20, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed